Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
214.10
-1.80 (-0.83%)
Jul 2, 2026, 3:14 PM AST
TADAWUL:4013 Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, TADAWUL:4013 stock has a consensus rating of "Buy" and an average price target of SAR 270.54. The average 1-year stock price forecast is 26.36% higher than the current stock price, while the lowest is SAR 181.00 (-15.46%) and the highest is SAR 320.00 (+49.46%).
Price Target: SAR 270.54 (+26.36%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TADAWUL:4013 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 8 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 3 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 2 | 2 |
| Total | 12 | 12 | 12 | 13 | 14 | 14 |
Financial Forecast
Revenue This Year
15.60B
from 13.71B
Increased by 13.79%
Revenue Next Year
17.46B
from 15.60B
Increased by 11.96%
EPS This Year
7.43
from 6.86
Increased by 8.34%
EPS Next Year
8.93
from 7.43
Increased by 20.18%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.1B | ||
| Avg | 15.6B | ||
| Low | 15.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.1% | ||
| Avg | 13.8% | ||
| Low | 9.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.56 | ||
| Avg | 7.43 | ||
| Low | 6.22 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 24.8% | ||
| Avg | 8.3% | ||
| Low | -9.3% |